ICD-10 Code L52: Erythema nodosum diagnosis, coding, and documentation

Key Takeaways

ICD-10 Code L52 is a billable ICD-10-CM code for erythema nodosum, a panniculitis presenting as tender erythematous nodules on the anterior shins

L52 is valid for HIPAA-covered transactions from October 1, 2025 through September 30, 2026 under the FY2026 release

An Excludes1 note means tuberculosis erythema nodosum (A18.4) must never be coded alongside L52; miscoding this is a common denial trigger

Pabau’s claims management software and digital intake forms help dermatology and skin practices assign and audit codes like L52 with HIPAA-compliant documentation

ICD-10 Code L52 is the billable ICD-10-CM code for erythema nodosum, a panniculitis that presents as tender, erythematous nodules, most often on the anterior shins. It’s valid for HIPAA-covered transactions under the FY2026 release, effective October 1, 2025 through September 30, 2026.

The code carries an Excludes1 note. When tuberculosis is the underlying cause, A18.4 applies instead, and the two codes can never be billed together. Here’s how to code L52 correctly, document it defensibly, and avoid the mismatch that gets claims kicked back.

ICD-10 Code L52: Code details and validity

ICD-10 Code L52 is a billable, specific ICD-10-CM code with no further sub-codes. It applies to erythema nodosum without a confirmed tuberculous cause. For practices using HIPAA-compliant practice software, accurate code assignment feeds directly into cleaner claims and fewer audit flags.

The table below summarizes the core metadata for L52 as published in the FY2026 ICD-10-CM Tabular List, effective October 1, 2025 through September 30, 2026.

Per the ICD-10-CM web tool, L52 carries no sub-codes. It is a terminal, specific code with no further specificity breakdowns within the L52 category itself.

Clinical description of erythema nodosum

Erythema nodosum is a delayed hypersensitivity reaction of the dermis and subcutaneous fat, classified formally as a panniculitis. It presents as tender, erythematous nodules, most commonly on the anterior shins, though lesions can also appear on the calves, thighs, and forearms.

The nodules typically range from 1 to 5 cm in diameter. They start as bright red, raised lesions, then evolve over one to two weeks through a bruise-like color progression from purple to yellow-green before resolving. This color shift is what separates erythema nodosum from M79.3.

• Location: Anterior shins (most common), calves, thighs, occasionally forearms
• Morphology: Tender, erythematous, indurated nodules 1-5 cm
• Color progression: Bright red to purple to yellow-green over 1-2 weeks
• Systemic signs: May accompany fever, arthralgias, malaise
• Resolution: Usually self-limiting within 3-6 weeks; no ulceration, no scarring

The absence of ulceration is a clinically important negative finding to document. Ulcerating nodules suggest a different diagnosis and a different ICD-10 code assignment.

Etiology and associated conditions

Erythema nodosum is rarely idiopathic in adults. An underlying trigger is identified in roughly 50% of cases, and ICD-10-CM Official Guidelines Section I.C requires dual-coding that condition alongside L52 once it’s established and documented.

Practices using skin clinic software that supports multi-code entries avoid the manual workarounds that undercode claims.

Excludes notes and coding pitfalls for ICD-10 Code L52

The single most important rule for L52 is its Excludes1 note. Under ICD-10-CM conventions, an Excludes1 note means the excluded condition is mutually exclusive with the code bearing the note. These two codes should never appear together on the same claim.

ICD-10 Code L52 applies only when erythema nodosum has no documented tuberculous cause. If confirmed mycobacterial disease is the underlying trigger, A18.4 is the correct code instead, and L52 is excluded entirely. Compliance management tools that flag Excludes1 conflicts at the point of coding catch this before it reaches the payer as a claim error.

The exclusion isn’t unique to dermatology. J65 follows the same logic, building TB confirmation into the code itself for a respiratory diagnosis. ICD-10-CM treats tuberculosis as a code-changing detail across chapters, not only in skin conditions.

Three common miscoding scenarios to avoid:

• Coding L52 when the chart documents active tuberculosis (use A18.4, not L52)
• Coding L52 and A18.4 together on the same claim (Excludes1 prohibits this)
• Omitting the underlying etiology code when sarcoidosis or streptococcal infection is documented

Documentation requirements for L52

Dermatology and primary care practices billing L52 need documentation that supports both the clinical diagnosis and the code’s billable status. Vague chart entries like “skin nodules” or “rash on legs” will not support L52 on audit. The CMS ICD-10 codes page sets the expectation that the medical record supports the coded diagnosis with sufficient clinical detail.

When the presentation is atypical, a physician may confirm the diagnosis with a tangential skin biopsy, billed separately using CPT code 11102. Structured digital intake forms that capture morphology, anatomical site, associated symptoms, and prior diagnostic workup give coders the raw material they need to assign L52 confidently. The checklist below reflects what the medical record must contain before L52 assignment is defensible.

• Clinical presentation: Document tender, erythematous nodules with location (anterior shins or other sites) and approximate size
• Color and evolution: Note whether lesions are evolving through the characteristic color progression
• Absence of ulceration: Explicitly document that nodules are non-ulcerating
• Systemic symptoms: Record any associated fever, arthralgias, or malaise
• Tuberculosis work-up: Document TB status, PPD/IGRA result, or clinical reasoning excluding tuberculous etiology
• Underlying etiology: Note whether a trigger (sarcoidosis, streptococcal infection, IBD, drug, pregnancy) was identified or ruled out
• Treatment plan: Document management approach, including NSAIDs, potassium iodide, compression, rest, or an intralesional corticosteroid injection (billed as CPT code 11901) for persistent nodules

ICD-10-CM guidelines require that documentation support the coded diagnosis directly in the medical record, not just inferred from the code itself. Clinical documentation software that prompts for the fields above at the point of care makes that support easier to produce on audit.

Differential diagnosis coding

Several conditions mimic erythema nodosum clinically, particularly in early presentations before lesions evolve. Coding the differential accurately when the diagnosis is not yet confirmed requires using the “probable” or “suspected” diagnosis conventions of ICD-10-CM, which differ from inpatient to outpatient settings. For outpatient encounters, code the presenting sign or symptom, not an unconfirmed diagnosis.

When the diagnosis is confirmed, the table below helps coders distinguish L52 from the most common mimics, each with its own specific code, including L54.

Related and adjacent ICD-10 codes

ICD-10 Code L52 sits within block L49-L54 (Urticaria and erythema) in Chapter 12. Understanding the adjacent codes helps coders navigate the block when the presenting diagnosis is uncertain or when multiple skin conditions are documented, including panniculitis variants like M35.6 that sit in a different chapter entirely.

For crosswalk purposes, the AAPC ICD-10-CM code lookup provides adjacent code navigation with notes on related categories within the L49-L54 block.

DRG and hospital billing considerations

For inpatient hospital encounters where erythema nodosum is the principal diagnosis or a significant comorbidity, ICD-10 Code L52 maps to Medicare Severity Diagnosis Related Groups (MS-DRGs). The DRG split is a two-tier structure: assignment depends on whether a major complication or comorbidity (MCC) is documented alongside the case.

DRG weights and reimbursement rates change annually with CMS updates. The figures above reflect the FY2026 grouper. Verify current weights against CMS’s published IPPS final rule. Practices managing inpatient coding workflows should use claims management software to track DRG assignments and flag when a documented MCC may support the higher-weight DRG.

How Pabau supports accurate ICD-10 coding in dermatology

Dermatology and skin practices coding conditions like erythema nodosum need documentation with enough specificity to support the code, captured at the point of care rather than reconstructed from memory during billing. Dermatology EMR software purpose-built for skin conditions structures documentation around the clinical criteria coders need.

Pabau’s patient records module supports structured clinical notes with configurable templates, allowing clinicians to document lesion morphology, location, color stage, and differential diagnosis work-up in a consistent format. Combined with before-and-after photo tracking that logs lesion history over time, practices keep what was observed in sync with what gets billed.

For practices managing billing across multiple skin conditions, Pabau’s workflow tools help flag missing documentation before claims are submitted. Book a demo to see how Pabau supports dermatology coding workflows: pabau.com/book-demo.

Accurate dermatology coding starts with better documentation

Pabau helps skin and dermatology practices structure clinical notes, capture intake data, and manage claims with HIPAA-compliant records built for ICD-10 workflows.

Book a demo

Conclusion

ICD-10 Code L52 is a specific, billable code with a narrow scope. It covers non-tuberculosis erythema nodosum only. The Excludes1 note is the single highest-risk coding point. Conflating L52 with A18.4 produces a claim error that is both a denial trigger and an audit flag. When the underlying condition is documented, dual-coding is required.

Dermatology and skin practices that structure their documentation around the clinical criteria L52 demands will code it cleanly and defend it confidently. Pabau’s client record and claims management tools make that structure part of the clinical workflow rather than a billing afterthought.

Continue your research

Need a compliant skin assessment framework? Skin assessment tools provides a structured guide to clinical skin documentation for aesthetic and dermatology practitioners.

Managing HIPAA compliance across clinical workflows? HIPAA compliance guide covers the documentation and operational requirements for HIPAA-covered transactions.

Looking at how dermatology EMR supports coding accuracy? Aesthetic EMR software explains how purpose-built EMR tools improve coding and documentation workflows for skin practices.

Frequently asked questions